Stocks and InvestingStocks and Investing
Fri, April 8, 2022
Thu, April 7, 2022
Wed, April 6, 2022
Tue, April 5, 2022

Arlinda Lee Maintained (XFOR) at Strong Buy with Decreased Target to $10 on, Apr 5th, 2022


Published on 2024-10-27 20:17:49 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $20 to $10 on, Apr 5th, 2022.

Arlinda has made no other calls on XFOR in the last 4 months.



There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Arlinda's Rating of Hold.



This is the rating of the analyst that currently disagrees with Arlinda


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, December 14th, 2021